ADIPOQ and cancer: Adiponectin activates cellular functions and pathways via peroxisome proliferator‐activated receptor and AMPK that inhibit mTOR, PI3K, and STAT3 (the last via suppressing cytokine signaling 3), inhibiting cancer cell proliferation and progression.